Aim: To examine whether (-)-stepholidine (SPD) has a direct effect on the Nmethyl-D-aspartic acid receptors (NMDAR) containing the NMDA receptor subunits NR2A or NR2B and to compare its effect with those of haloperidol (Hal) and clozapine (Cloz). Methods: NMDAR was transiently expressed in human embryonic kidney 293 (HEK293) cells. Changes in intracellular calcium concentration ([Ca 2+ ] i ) induced by NMDAR activation were monitored with Fura-2 ratio imaging techniques. Results: SPD had no significant effects on either subunit of NMDAR at a concentration of less than 100 µmol/L. Hal selectively inhibited NMDAR containing the NR2B subunit, whereas Cloz inhibited both subunits of NMDAR. Although both Hal and Cloz inhibited NR1a/NR2B receptor-mediated Ca 2+ influx, their effects were different. Hal was more potent and had a faster peak effect than Cloz. Conclusion: Both Hal and Cloz inhibit NMDAR-mediated function, whereas SPD produced only a little inhibition at a high concentration. Based on our other studies, the modulation of SPD on NMDAR function may be via D 1 receptor action underlying an indirect mechanism.
Introduction
Animal and imaging data support a novel model of schizophrenia that putative brain dopamine (DA) function imbalance, that is, the subcortical D 2 receptor (D 2 R) hyperfunction and prefrontal cortical (PFC) D 1 receptor (D 1 R) dysfunction, may be sequential to NMDA receptor (NMDAR) hypofunction in the PFC [1, 2] . NMDAR are ligandgated ion channels and are composed of multiple subunits (NR1, NR2A-D, and NR3A-C) [3] . A remarkable property of NMDAR is its high permeability to the calcium ion (Ca 2+ ). Several studies have shown that neuro-leptics may affect influence NMDAR directly or indirectly. Haloperidol (Hal), a typical neuroleptic, is a potent antagonist of D 2 R. The cyclic AMP (cAMP) pathway is enhanced by Hal via its D 2 R blockage and it can phosphorylate the NR1 subunit of the NMDAR, which is necessary for neuroleptic-mediated gene expression and may contribute to the therapeutic benefits as well as side effects of neuroleptics treatment [4] . Clozapine (Cloz), an atypical neuroleptic, is effective in treating positive and negative syndromes of schizophrenia and refractory schizophrenia. In contrast to Hal, Cloz treatment induces relatively few extrapyramidal side effects [5] . A number of neurotransmitters and receptors, including Glu, DA, could contribute to Cloz's atypical profile and clinical efficacy [6] . Cloz, but not Hal, can facilitate Glu receptor-mediated neurotransmission in the PFC [7] . A direct interaction of neuroleptics with NMDAR has been demonstrated. Hal has been shown to inhibit NMDAR function in a subunit-selective manner with NR2B-containing receptors displaying more sensitivity to the drug than non-NR2B-containing receptors [8] . Cloz, on the other hand, inhibits both NR2A and NR2B-containing NMDAR [9] . It is noted that these effects of Hal and Cloz would be counteractive to their therapeutic effects since blockade of NMDAR exacerbates symptoms in schizophrenia [10] .
(-)-Stepholidine (SPD) is a tetrahydroprotoberberine alkaloid isolated from the Chinese herb Stephania. Our previous studies have shown that SPD is an agonist at D 1 R, but acts as antagonist at D 2 R [2] . SPD exhibits a profile similar to that of atypical neuroleptics [2, [11] [12] [13] . More recently, it has been shown that SPD possesses agonist action on D 1 R in the PFC pyramidal glutamic (Glu) neuron, by which it modulates firing activity of nucleus accumbens neurons [14] ; it mimics the effect of Cloz, preferentially increasing c-fos expression in the PFC via DA and non-DA systems [15] . Moreover, it has been found that SPD (0.1-10 µmol/L) can potently enhance synaptically-evoked NMDA EPSC (excitatory postsynaptic currents) in PFC neurons recorded in brain slices [16] ; SPD (50 µmol/L) also increased the amplitude under the similar brain slices experiments [17] . However, little is known about the effect of SPD on NMDA receptors by direct or indirect mechanisms at the molecular level.
This study is intended to elucidate whether SPD has a similar pharmacological property to NMDAR as Cloz or whether it is different from Cloz and Hal, using Ca 2+ imaging techniques for studying NMDAR function. The calcium imaging technique has an advantage in studying NMDAR function without change of intracellular conditions, which is different from patch clamp recording. The latter might cause alterations in the concentrations of intracellular constituents, such as protein kinase or phosphatase (important constituents in modulating NMDAR activity). The direct effects of SPD were compared with Hal and Cloz on cloned NMDAR transiently expressed in HEK293 cells. Chinese Academy of Sciences, Shanghai, China), were maintained in DMEM supplemented with 10% newborn calf serum, 100 U/mL penicillin, and 100 U/mL streptomycin. The cells were plated at 2.5×10 4 onto acid-washed, poly-L-lysine coated glass coverslips (20 mm×20 mm). Transfections were performed when cell confluence reached about 80%. Rat NR1a, NR2A, or NR2B (generous gifts from Dr John WOODWARD, Medical University of South Carolina, Charleston, SC, USA), and enhanced green fluorescent protein (EGFP) plasmids were delivered at a ratio of 1:1:1 by the calcium-phosphated precipitation method with the modification of an additional 1 mmol/L ketamine to prevent excitotoxity during transfections [18] . After transfection and incubation for 24 h, the cells were used for the experiments. EGFP was used to identify the transfected cells.
Materials and methods

Materials
Calcium imaging [19] The transfected cells were incubated with Fura-2 AM (4 µmol/L with 0.025% pluronic-127) for 45 min at 37 °C in extracellular solution (135 mmol/L NaCl, 5.4 mmol/L KCl, 1.8 mmol/L CaCl 2 , 10mmol/L glucose, and 5 mmol/L HEPES (2-[4-(2-Hydroxyethyl)-1-piperazinyl] ethanesulfonic acid); pH (6.8). After washing 3 times with Fura-free extracellular solution (pH 7.2), the dishes were mounted on the stage of an Olympus BX51WI upright microscope (Tokyo, Japan) and perfused continuously with modified Ringer's solution at a flow rate of 1.2-1.5 mL/min. l-Glu/Gly were applied via a computer-controlled Y-tube (outer ϕ=100 µm) situated 80 µm above the cells. The cells were exposed to the alternating 340 nm and 380 nm light from a xenon lamp via DG4 (Sutter Instrument Company, Novato, CA, USA) every 2 s during and immediately after Glu/Gly application, and the images were acquired via a charge coupled device (CCD) camera (CoolSNAP HQ, Roper Scientific, Duluth, GA, USA). To minimize UV exposure, images were taken every 15-60 s between drug applications. Ratio images were generated using MetaFlour software from Universal Imaging (West Chester, PA, USA). Intracellular calcium concentrations ([Ca 2+ ] i ) were determined by the ratio of the intensity of the wavelengths at 340 and 380 nm. NMDAdependent increases in [Ca 2+ ] i were calculated by subtracting the average baseline value from the peak value obtained during Glu/Gly application. SPD, Hal, and Cloz were applied throughout the bath.
Data analysis Data were analyzed using Origin 6.0 (OriginLab Corporation, Northampton, MA, USA) and expressed as mean±SEM. The statistical significance of a drug's effect was determined by comparing measures before and after drug injection using ANOVA followed by a post-hoc Tukey test [20] . Although both Hal and Cloz inhibited the function of the NR1a/NR2B receptor, their effects were not entirely identified. Hal was much more potent than Cloz. Hal (0.1 µmol/L) inhibited Glu/Gly-induced Ca 2+ influx (P<0.01, n=21), while Cloz produced no inhibition at the same concentration. However, when the concentration reached 10 µmol/L, Cloz inhibited the Glu/Gly-induced Ca 2+ influx (Figure 3) . The speed for Hal and Cloz operation also differed. Hal produced its peak effect at about 5 min after onset, while the maximal inhibition induced by Cloz required a 30 min perfusion. However, the effects of both Hal and Cloz were much less potent than that of MK-801 ( Figure 2C) .
Results
Calcium imaging study of NMDA receptor function
Effects of SPD, Hal, and Cloz on the NR2A subunit of NMDA receptors Cloz, not SPD (100 µmol/L) or Hal (50 µmol/L), significantly inhibited the function of the NR1a/ NR2A receptor ( Figure 4A, 4B) . Cloz produced an average of 31.2%±4.2% (P<0.01, n=9) and 59.2%±5.8% (P<0.01, n=9) inhibition at 10 µmol/L and 100 µmol/L, respectively. A similar result was observed with the NR1a/NR2B receptors. Cloz also showed a slow onset in its effect on the NR1a/NR2A receptors ( Figure 4A , lower section), which took 30 min to reach the maximum effect.
Discussion
The results of the present study found that SPD did not interact with the NR1a/NR2A or NR1a/NR2B receptors at low concentrations, unless 100 µmol/L SPD elicited certain inhibitory effects on NR1a/NR2B receptor-mediated Ca 2+ influx. It appeared that SPD did not interact directly with NMDAR. In contrast with SPD, Hal and Cloz produced significant inhibitory effect on NMDAR-mediated Ca 2+ influx. However, Hal selectively blocked the NR1a/NR2B receptors, whereas Cloz inhibited both NR1a/NR2B-and NR1a/NR2A-mediated responses.
In a previous study [8] , Hal inhibited the function of NMDAR in a subunit-selective manner, with the NR2B-containing receptor more sensitive to the drug. However, Cloz inhibited Ca 2+ influx mediated by both the NR2A and NR2B subunits of NMDAR [9] . Our results of Hal and Cloz were similar to the above mentioned both reports. Therefore, the different effects of the 3 drugs on NMDAR function may imply that SPD, Hal, and Cloz have different mechanisms in its antipsychotic use. In other words, Hal and Cloz have direct interaction with NMDAR, while SPD has an indirect one [21] . Our results showed that the significant inhibitory effect on Ca 2+ influx by Hal was observed at 0.1 µmol/L, while Cloz was at 1 µmol/L. However, the clinic plasma concentration of Hal and Cloz could reach 8-35 ng/mL (0.021-0.093 µmol/L) [22] and 350 ng/mL (1.07 µmol/L) [23, 24] , respectively, at which the 2 drugs may display their inhibitory effects on NMDAR-mediated Ca 2+ influx. So what is the meaning of this inhibitory effect? There are two aspects with a contradiction. The inhibitory effect induced by Hal or Cloz is implicated to be beneficial for the negative symptoms of schizophrenia [25, 26] . Alternatively, the inhibition of Hal and Cloz on NMDAR would limit their clinical therapeutic effect [27, 28] . It may be suggested that the inhibition induced by Hal or the Cloz D 2 R blockade is the result of the inhibitory effect on the PFC NMDAR; subsequently, the inhibition would deteriorate the therapeutic effect, based on the DA function imbalance hypothesis [1, 2] . As to the indirect interaction between SPD and NMDAR, we obtained definite evidence requiring postsynaptic density-95 (PSD-95) [21] . In an in vitro study, when PSD-95 was co-expressed with D 1 R and NMDAR in HEK293 cells, the activation of D 1 R could enhance NMDAR-mediated Ca 2+ influx [21] . SPD hence could not display its enhancing effect on NMDAR under such experimental conditions without PSD-95. In the present study, SPD also could not affect NMDAR directly in this in vitro expression system for lack of D 1 R and other components.
On the other hand, in the experiment of brain PFC slices, including endogenic D 1 R and PSD-95, the patch clamp study recently demonstrated that SPD could increase the amplitude [17] or frequency [16] of sEPSC recording from the NMDAR of PFC pyramidal cells, respectively. Furthermore, the D 1 R agonist of SPD is mediated via intracellular protein kinase A and protein kinase C signaling pathways [16] . These results also strongly support that the D 1 R agonist of SPD enhances the NMDAR effect. Nevertheless, the enhancement of SPD on the NMDAR is obviously different from the inhibition elicited by Hal or Cloz on the NMDAR. According to these findings, 3 possible pathways have being proposed to explain how SPD can enhance NMDAR-mediated neurotransmission in the PFC. First, SPD possesses a unique D 1 R agonist effect [2] , and the activation of D 1 R has been shown to enhance NMDAR-mediated responses in PFC neurons [16, 29] . Second, SPD may act through the D 1 R to either enhance synaptic Glu release or to increase the response of the cell to NMDAR activation [16, 17] , as Cloz has been shown to increase spike-dependent presynaptic Glu release [30] . Third, SPD could result in a part effect through non-DA systems [15] . However, which class of non-DA receptors is responsible for the enhancing effect of SPD on NMDAR is still unknown.
Our results indicate that unlike Hal and Cloz, SPD did not directly affect the function of NMDAR at a low concentration. It is presumed that the modulatory effect of SPD on NMDAR function is an indirect effect via the D 1 R [16, 21] .
